These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17943947)

  • 21. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
    Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
    Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
    Wickline SA; Neubauer AM; Winter PM; Caruthers SD; Lanza GM
    J Magn Reson Imaging; 2007 Apr; 25(4):667-80. PubMed ID: 17347992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity.
    Gao J; Kou G; Wang H; Chen H; Li B; Lu Y; Zhang D; Wang S; Hou S; Qian W; Dai J; Zhao J; Zhong Y; Guo Y
    Breast Cancer Res Treat; 2009 May; 115(1):29-41. PubMed ID: 18481173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.
    Acharya S; Dilnawaz F; Sahoo SK
    Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional nanoparticles--properties and prospects for their use in human medicine.
    Sanvicens N; Marco MP
    Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy.
    Sun Y; Chen ZL; Yang XX; Huang P; Zhou XP; Du XX
    Nanotechnology; 2009 Apr; 20(13):135102. PubMed ID: 19420486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal nanomedicine for breast cancer therapy.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmonic magnetic nanostructure for bimodal imaging and photonic-based therapy of cancer cells.
    Lim YT; Cho MY; Kim JK; Hwangbo S; Chung BH
    Chembiochem; 2007 Dec; 8(18):2204-9. PubMed ID: 17957817
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted nanoblobs spot treat cancer and heart disease.
    Wolfson W
    Chem Biol; 2006 Apr; 13(4):343-5. PubMed ID: 16632245
    [No Abstract]   [Full Text] [Related]  

  • 33. Locoregional cancer treatment with magnetic drug targeting.
    Alexiou C; Arnold W; Klein RJ; Parak FG; Hulin P; Bergemann C; Erhardt W; Wagenpfeil S; Lübbe AS
    Cancer Res; 2000 Dec; 60(23):6641-8. PubMed ID: 11118047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
    Gindy ME; Prud'homme RK
    Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomedical nanotechnology for cancer.
    Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
    Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
    Yu MK; Jeong YY; Park J; Park S; Kim JW; Min JJ; Kim K; Jon S
    Angew Chem Int Ed Engl; 2008; 47(29):5362-5. PubMed ID: 18551493
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted delivery of multifunctional magnetic nanoparticles.
    McCarthy JR; Kelly KA; Sun EY; Weissleder R
    Nanomedicine (Lond); 2007 Apr; 2(2):153-67. PubMed ID: 17716118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nanomedicine: chance or risk for the patients?].
    Kathmann W
    Dtsch Med Wochenschr; 2009 May; 134(19):p19. PubMed ID: 19424944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.